Article Text
Editorial
Taking the ‘Disease’ out of ‘Parkinson’s’: has the disease had its day?
Statistics from Altmetric.com
Footnotes
Contributors PFW is the sole contributor to this work.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned. Externally peer reviewed by David Burn, Newcastle-upon-Tyne, UK.
Read the full text or download the PDF:
Other content recommended for you
- Parkinson's disease: chameleons and mimics
- Fifty years of progressive supranuclear palsy
- Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
- Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome
- Parkinson’s disease: clinical features and diagnosis
- Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy
- Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes
- The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study